{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-26-000523","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.787469+00:00","generated_at":"2026-05-16T10:05:21.746929+00:00","sec_items":["1.01","2.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Boston Scientific to acquire Penumbra: $374 cash or 3.8721 BSX shares per share; 73% cash/27% stock","bullets":["Penumbra holders elect $374 cash or 3.8721 BSX shares per share; proration targets 73.26% cash/26.74% stock.","Termination: Penumbra pays $525M if it accepts superior offer; Boston Sci pays $900M if antitrust fails.","Closing subject to Penumbra stockholder vote, HSR and foreign antitrust clearance, S-4 effectiveness, NYSE listing.","Preliminary Q4/FY2025 results released; audited financials pending, specific figures not in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-000523","json":"https://secwatch.observer/filing/0000950103-26-000523.json","markdown":"https://secwatch.observer/filing/0000950103-26-000523.md","text":"https://secwatch.observer/filing/0000950103-26-000523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000095010326000523/0000950103-26-000523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000095010326000523/dp240008_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:05:21.746929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c783b1e0bf020ef172884b04abc7c08b53d0d5fa","claim":"Penumbra Inc entered into Agreement and Plan of Merger with Boston Scientific Corporation (effective 2026-01-14).","evidence_excerpt":"On January 14, 2026, Penumbra, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) among the Company, Boston Scientific Corporation, a Delaware corporation (“Parent”), and Pinehurst Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving as a wholly owned subsidiary of Parent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000095010326000523/0000950103-26-000523-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Boston Scientific Corporation"},{"label":"Effective","value":"2026-01-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}